Entyvio by Takeda UK is First UC Maintenance to Receive NICE Approval
News, Ulcerative colitis
Takeda UK, a subsidiary of Japan’s leading pharmaceutical company, recently achieved a pioneering milestone when the National Institute for Health and Care Excellence (NICE) granted Entyvio® (vedolizumab) a positive provisional recommendation in the ... Read more